Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner was added announcing an NIH website transition and noting that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.9%
    Check dated 2026-10-24T13:23:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer site revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:26:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T13:17:40.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The history view updates the label from 'Find Contact Information' to 'Find contact information', and the revision tag changes from v3.6.6 to v3.7.0, reflecting a UI copy standardization and a new version.
    Difference
    0.3%
    Check dated 2026-09-19T14:08:42.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-29T14:05:25.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4, signaling a new site release of the ClinicalTrials.gov interface on the study history page.
    Difference
    0.1%
    Check dated 2026-08-08T12:31:31.000Z thumbnail image

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.